Author

Francine Siedlecki

Institution: Roswell Park Comprehensive Cancer Center

Observed institution: Roswell Park Comprehensive Cancer Center

OpenAlex ID: A5033534748

A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers.

2015 · Hatoon Bakhribah, Grace K. Dy, et al. · Journal of Clinical Oncology · 15

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

2017 · Sidra Anwar, Wei Tan, et al. · Cancers · 11

Evaluation of Quality-of-life (QoL) in patients(pts) with advanced solid tumors as screening tool during phase 1 clinical trial recruitment- risk assessment for adverse events and subject replacement.

2015 · Sidra Anwar, Wei Tan, et al. · Journal of Clinical Oncology · 2

Works count: 3

Citation count: 28

H-index: 2

I10-index: 2